Home

Paradox Elefant Jede Woche clopidogrel loading dose nstemi Verrat Schreibkraft Tsunami

Doses of antiplatelet co-therapies | Download Table
Doses of antiplatelet co-therapies | Download Table

Antiplatelet therapy for STEMI - ppt download
Antiplatelet therapy for STEMI - ppt download

ESC Guidelines on oral P2Y12 antiplatelet therapy in ACS. | Download Table
ESC Guidelines on oral P2Y12 antiplatelet therapy in ACS. | Download Table

Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in  Patients With Planned Percutaneous Coronary Intervention | Circulation
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation

Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel  Loading Dose Compared With a Prasugrel Loading Dose Alone | Circulation:  Cardiovascular Interventions
Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose Alone | Circulation: Cardiovascular Interventions

DAY 3 - Acute Coronary Syndromes — The Intern at Work
DAY 3 - Acute Coronary Syndromes — The Intern at Work

Effectiveness of reloading to overcome clopidogrel nonresponsiveness in  patients with acute myocardial infarction. | Semantic Scholar
Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction. | Semantic Scholar

Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation  Myocardial Infarction Undergoing Primary Angioplasty
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty

Antiplatelet and anticoagulation regimen in patients with mechanical valve  undergoing PCI – State-of-the-art review - International Journal of  Cardiology
Antiplatelet and anticoagulation regimen in patients with mechanical valve undergoing PCI – State-of-the-art review - International Journal of Cardiology

2018 Canadian Cardiovascular Society/Canadian Association of Interventional  Cardiology Focused Update of the Guidelines for the Use of Antiplatelet  Therapy - Canadian Journal of Cardiology
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy - Canadian Journal of Cardiology

Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation  Myocardial Infarction Undergoing Primary Angioplasty: Results From the  HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in  Acute Myocardial Infarction) Trial ...
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty: Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial ...

Risk stratification and medical management of NSTE-ACS (UA/NSTEMI ) - ppt  video online download
Risk stratification and medical management of NSTE-ACS (UA/NSTEMI ) - ppt video online download

Antiplatelet therapy in coronary artery disease
Antiplatelet therapy in coronary artery disease

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes |  NEJM
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes | NEJM

Antithrombotic strategies in elderly patients with acute coronary syndrome  - ScienceDirect
Antithrombotic strategies in elderly patients with acute coronary syndrome - ScienceDirect

Randomized Trial of High Loading Dose of Clopidogrel for Reduction of  Periprocedural Myocardial Infarction in Patients Undergoing Coronary  Intervention | Circulation
Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention | Circulation

Overview of Antiplatelet Therapy for Myocardial Infarction | Thoracic Key
Overview of Antiplatelet Therapy for Myocardial Infarction | Thoracic Key

Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in  Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous  Coronary Intervention: A Randomized Clinical Trial | Journal of the  American Heart Association
Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial | Journal of the American Heart Association

PDF) Is There Safety in the Use of Clopidogrel Loading Dose in Patients  Over 75 Years of Age with Acute Coronary Syndrome?
PDF) Is There Safety in the Use of Clopidogrel Loading Dose in Patients Over 75 Years of Age with Acute Coronary Syndrome?

Treatment of NSTEMI (Non-ST Elevation Myocardial Infarction) | SpringerLink
Treatment of NSTEMI (Non-ST Elevation Myocardial Infarction) | SpringerLink

Standard versus high loading doses of clopidogrel in Asian ST-segment  elevation myocardial infarction patients undergoing percutaneous coronary  intervention: Insights from the Korea Acute Myocardial Infarction Registry  - ScienceDirect
Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry - ScienceDirect

ST-Segment Elevation Myocardial Infarction:What Role for Anticoagulants and  Antiplatelet Agents? | Consultant360
ST-Segment Elevation Myocardial Infarction:What Role for Anticoagulants and Antiplatelet Agents? | Consultant360

PLATO – TIMI STUDY GROUP
PLATO – TIMI STUDY GROUP

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or  older with non-ST-elevation acute coronary syndrome (POPular AGE): the  randomised, open-label, non-inferiority trial - The Lancet
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial - The Lancet

Pharmacodynamic study of prasugrel or clopidogrel in non-ST-elevation acute  coronary syndrome with CYP2C19 genetic variants undergoing percutaneous  coronary intervention (PRAISE-GENE trial) - International Journal of  Cardiology
Pharmacodynamic study of prasugrel or clopidogrel in non-ST-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention (PRAISE-GENE trial) - International Journal of Cardiology

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose  aspirin in individuals undergoing percutaneous coronary intervention for  acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial -  The Lancet
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial - The Lancet

2020 APSC Recommendations on use of P2Y12 inhibitors in Asia
2020 APSC Recommendations on use of P2Y12 inhibitors in Asia